Trial intelligence / Profile preview

Opioid Free Anesthesia in Breast Cancer Surgery

NCT04390698Completed

Sponsor
Peking University People's Hospital
Start
Jul 2020
Primary completion
Mar 2021
Modality
Orthosteric Ligands
Countries
1
01

Overview

Randomised, double-blind trial of lidocaine and ropivacaine in breast cancer (2 arms), sponsored by Peking University People's Hospital. Primary endpoint: Quality of Recovery at 24 hours. Started Jul 2020; status: completed.

02

Drugs

lidocaineropivacaine
03

Conditions

breast cancer

Beyond the preview

Go deeper on NCT04390698.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04390698.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call